top headlines
multiQure has selected US contract development and manufacturing organisation (CDMO) [...]
Cereno Scientific has dosed the first patient in its global [...]
Movers & Shakers
sponsored content
Other news
Adcendo has reported a 30% objective response rate for its [...]
Pheno Therapeutics has secured two patents protecting its GPR17 antagonist [...]
Grifols has presented real-world data on therapeutic plasma exchange with [...]
ProMIS Neurosciences has licensed a brain-selective delivery technology from Ossianix, [...]
Dicot Pharma has started a Phase 2b clinical trial of [...]
Skylark Bio has received unanimous independent safety board support to [...]









